PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-08-01

Date Title Company
01-Aug-2024 Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time AccessWire
01-Aug-2024 Zoelife Psychiatric Services Receives Prestigious Accreditation for Outpatient Treatment for Adults, Children and Adolescents AccessWire
01-Aug-2024 Black Diamond Networks Announces European Expansion Newswire
01-Aug-2024 1upHealth Launches Customer Advisory Board to Advance Industry-Wide Interoperability and Fuel Technological Innovation AccessWire
01-Aug-2024 Animal Surgical Center Proudly Announces AAHA Accreditation: Leading the Way in Veterinary Excellence AccessWire
01-Aug-2024 Two Investigator-Initiated Responder Analysis Trials of Jaguar Health's Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting AccessWire
01-Aug-2024 enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update AccessWire
01-Aug-2024 Nitches Inc. Expands Into Bioceutical and Pharmaceutical Markets With New Subsidiary Newswire
01-Aug-2024 CBD Life Sciences, Inc. (CBDL) Signs MOU With Large Mushroom Supplement Company AccessWire
01-Aug-2024 RETRANSMISSION: Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports AccessWire
01-Aug-2024 Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows AccessWire
01-Aug-2024 FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate AccessWire
01-Aug-2024 OMS360 Appoints Dr. Joshua Everts as Chief Clinical Officer AccessWire
01-Aug-2024 Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports AccessWire
01-Aug-2024 Bausch Health Announces Second Quarter 2024 Results AccessWire
01-Aug-2024 Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG Vita 34 AG
01-Aug-2024 Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update Immunic AG
01-Aug-2024 Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET AccessWire
01-Aug-2024 "NanoViricides Broad Spectrum Technology Represents Potential Paradigm Shift In Viral Therapy"; "Novel Anti-Viral Could Boost a US$3 Billion Market" - Conclude Two Independent Research Reports on NanoViricides AccessWire
01-Aug-2024 Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates AccessWire